It’s only a coincidence that my last blog was about Stephen Colbert’s “Cheating Death” segment and today’s is about Dr. Sanjay Gupta’s “Cheating Death” book.
Marshall Scott, man of the cloth, publisher of the Episcopal Chaplain at the Bedside blog, critiques Gupta’s book.
His critique is especially relevant given the media ethics situation unfolding where Gupta reported on his own involvement in health care in Haiti. (This has now become a real trend, with CBS’ Dr. Jennifer Ashton and ABC’s Dr. Richard Besser reporting on their own involvement in health care episodes in Haiti. I’ll address this more fully in a future post.)
Reverend Scott writes:
“…that Dr. Gupta the reporter has overcome Dr. Gupta the physician in his effort to tell the story. …
This is an interesting and readable book. Unfortunately, for all the qualifications of Dr. Gupta the doctor, this book from Dr. Gupta the reporter shows all the shortcomings of health journalism. It brings out possibilities well before they’re going to be generally accepted, much less available. It highlights the successes without making clear the limitations, and especially the limitations in how many patients might actually be appropriate recipients of the therapies. Finally, while it uses research to support the story, it does so poorly, relying primarily on anecdotal reports and using published research imprecisely. Yeah, it’s an interesting read. Unfortunately, it might just create more problems than it solves.”
Read Rev. Scott’s entire blog entry. As a hospital chaplain, he’s a smart observer of health care and of health care journalism.
Opinions on other issues in news, journals, PR, advertising, marketing
Like Michael Corleone of science reporting that @garyschwitzer is (he tries to get out, bullshit disguised as #science #journalism keeps pulling him back in!), he drops this on @nytimes idiocy 🙄 in reporting T1 diabetes "cure"
HT @HealthNewsRevu
https://www.healthnewsreview.org/2021/11/cure-for-type-1-diabetes-weve-been-down-this-road-before-with-ny-times/
A great read on this weekend’s NYT claims of a cure for Type 1.
Cure for Type 1 diabetes? We’ve been down this road before with NY Times https://www.healthnewsreview.org/2021/11/cure-for-type-1-diabetes-weve-been-down-this-road-before-with-ny-times/
"But it is the framing and the emphasis of the #journalism by a leading science journalist at a leading newspaper that demands scrutiny. It has an impact on readers and on sick people that may cause harm by promoting false hope about extremely preliminary research"
👍👏💪 truth https://twitter.com/garyschwitzer/status/1465399358137024518
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like